02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 703A<br />

multi-color flowcytometry we analyzed frequency and function<br />

of Tregs and effector T cells before and at the end of treatment<br />

(treatment week (TW) 12) from HCV-patients after succesful<br />

HCV elimination with sofosbuvir (SOF) in combination with<br />

IFN plus ribavirin (n=14) versus patients treated with SOF plus<br />

daclatasvir (DCV) and simeprevir (SMV), respectively (n=14).<br />

In addition, we measured serum levels of immunomodulatory<br />

cytokines. Results: Unlike IFN-free therapy, treatment with SOF<br />

plus IFN significantly increased numbers of peripheral Tregs<br />

(% Foxp3 + CD25 + CD4 + T cells TW0 vs. TW12 (MW±SD):<br />

5.5±2.0 vs. 7.2±2.4; p90%) of sustained<br />

virological response at week 12 (SVR12) in patients with<br />

HCV infection genotype 4 (Abergel et al. ILC 2015, J Hepatol<br />

2015; 62 (Suppl 2):S219; Poordad et al. ILC 2015, J Hepatol<br />

2015; 62 (Suppl 2):S261). In the former study, two of the three<br />

patients with virological relapse had a genotype 4r subtype.<br />

In the later, NS5A variants were found at baseline in 4 out of<br />

13 patients with virologic failure and in 13 out of 13 patients<br />

at failure. In addition, the number of pre-treatment baseline<br />

RAPs (Resistance Associated Polymorphisms) was associated<br />

with virological failure in a study conducted by Sarrazin et<br />

al. (AASLD, Hepatology 2014; 60 (Suppl) 1128A). Aim: The<br />

objective of this study was to assess the NS5A natural polymorphisms<br />

of the genotype 4 subtypes in order to investigate<br />

the potential role of subtypes and RAPs in treatment outcome<br />

with regimens containing an NS5A inhibitor. Methods: We<br />

collected from the NCBI, European, and Japanese HCV databases,<br />

47 HCV NS5A Genotype 4 sequences and proceeded<br />

to multiple Sequence Alignment using Clustal W2. We analyzed<br />

16 subtype 4a, 7 subtype 4b, 3 subtype 4d, 2 subtype<br />

4m, 3 subtype 4o and 16 subtype 4r (no 4c or 4f were available).<br />

We assessed the prevalence by subtypes of the main<br />

RAPs: L28M, L30R, L31M, P58T and Y93H. Results: Seventy<br />

five percent of the 16 genotype 4r strains included 2 RAPs<br />

(L30R and L31M), in comparison with the 16 genotype 4a<br />

which had only one RAP in all of the strains included (L31M)<br />

(p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!